Kristin Wynholds

Insider Reports History

Entity
Individual
Location
548 Market Street, #49404, San Francisco, California
Signature
/s/ Leslie Miller, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristin Wynholds:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Better Therapeutics, Inc. Chief Product Officer Common Stock 225,631 $38.3 K $0.17 Dec 18, 2023 Direct
Better Therapeutics, Inc. Chief Product Officer Stock Option (Right to Buy) 101,450 Mar 1, 2023 Direct

Insider Reports Filed by Kristin Wynholds

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BTTX Better Therapeutics, Inc. Dec 18, 2023 1 0 4 Dec 20, 2023 Chief Product Officer
BTTX Better Therapeutics, Inc. Mar 1, 2023 2 0 4 Apr 21, 2023 Chief Product Officer
BTTX Better Therapeutics, Inc. May 31, 2022 2 12,420 4 Dec 2, 2022 Chief Product Officer
BTTX Better Therapeutics, Inc. Apr 1, 2022 1 0 4 Apr 4, 2022 Chief Product Officer
BTTX Better Therapeutics, Inc. Oct 28, 2021 0 0 3 Nov 1, 2021 Chief Product Officer